Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00741078

Enrollment

Unknown

Registered

2008-08-26

Start date

2004-12-31

Completion date

2008-08-31

Last updated

2008-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

endothelial, function, insulin, sensitivity

Brief summary

The investigators hypothesized combination therapy would be superior to monotherapy.

Interventions

DRUGstatin, amlodipine

Study design

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

25 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Hypertension

Exclusion criteria

* Chronic renal disease * Severe hypertension

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026